ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Outcomes of Kidney Transplant Recipients (KTRs) Comparing Brain Dead Donors’ vs Donation After Cardiac Death Stratified by KDPI, Focus on Marginal Kidneys: A UNOS Database Analysis

B. Chopra1, K. K. Sureshkumar1, D. Rajasundaram2, E. C. Rodrigo3

1Allegheny Health Network, Pittsburgh, PA, 2UPMC, Pittsburgh, PA, 3University Hospital Marqués de Valdecilla, Santander, Spain

Meeting: 2021 American Transplant Congress

Abstract number: 131

Keywords: Cadaveric organs, Donors, non-heart-beating, Kidney transplantation, Outcome

Topic: Clinical Science » Kidney » Kidney Deceased Donor Selection

Session Information

Session Name: Kidney Deceased Donor Selection

Session Type: Rapid Fire Oral Abstract

Date: Sunday, June 6, 2021

Session Time: 4:30pm-5:30pm

 Presentation Time: 4:55pm-5:00pm

Location: Virtual

*Purpose: In deceased donor kidney transplantation (DDKT), donation after cardiac death (DCD) is associated with increased cytokine release and renal tubular injury with consequent increase in the risk for delayed graft function (DGF). These cascade of events could increase acute rejection (AR) risk and potentially impact graft and patient survival. The impact of donation after brain death (DBD) vs DCD status on the long term outcomes following DDKT has conflicting reports in the literature especially for transplants from marginal donors. The aim of this study was to compare the outcomes of DDKT from DBD vs DCD in groups stratified by different degrees of kidney donor profile index (KDPI).

*Methods: Using OPTN/UNOS database, we identified adult DDKT recipients from 2005 to 2019 who received induction followed by calcinurine inhibitor/mycophenolate mofetil maintenance. Patients were divided into 4 KDPI groups: 0-20%, 21-50%, 51-84% and ≥85%. In each KDPI category, short and long-term outcomes including DGF, AR, adjusted overall graft, death-censored graft, and patient survivals were compared between patients who received kidneys from DBD vs DCD donors.

*Results: There were 99548 DDKT recipients included in the study. Outcomes are shown in Table 1. Utilization of machine perfusion and the incidence of DGF were higher for kidneys from DCD donors across all KDPI groups (***=p <0.0001). The AR rates and patient survivals were similar for DBD vs DCD in all KDPI categories. The overall graft and death-censored graft survivals were similar in all KDPI categories except in 21-50% KDPI group, where DBD group had better outcomes (**= p<0.05). In particular, graft (over all and death-censored) and patient survivals were similar for DBD vs. DCD kidney recipients among the high KDPI (≥85%) group.

Results Table
KDPI (0-20%) N= 33581 KDPI (21-50%) N= 23400 KDPI (51-84%) N=33896 KDPI ≥ 85% N= 8671
DBD= 27739 vs DCD=5842 DBD= 20900 vs DCD=2500 DBD=27,718 vs DCD=6178 DBD= 7792 vs DCD= 879
Machine perfusion (%) 24.5% vs. 46.4% *** 15.7% vs. 40.6% *** 19.3% vs. 43.4% *** 34.4% vs 48.8% ***
Delayed Graft Failure (%) 27.3% vs. 45.5% *** 14.9% vs. 32.9% *** 22.7% vs. 42.8% *** 29.9% vs. 48.2% ***
Acute Rejection (%) 6.4% vs. 6.3% 5.1% vs. 5.5% 5.8% vs. 6.4% 7.5% vs. 6.1%
 Adjusted Graft Survival [HR(95%CI)] 0.99 (0.94-1.05) 1.12 (1.01-1.23) ** 1.00 (0.94-1.07) 1.02 (0.94-1.07)
Adjusted Death censored Graft Survival [HR(95%CI)] 1.02 (0.94-1.1) 1.21 (1.06-1.39) ** 1.02 (0.93-1.12) 1.03 (0.85-1.19)
Adjusted Patient Survival [HR(95%CI)] 1.04 (0.96-1.1) 0.94 (0.83-1.07) 1.02(0.94-1.1) 0.99 (0.86-1.15)

*Conclusions: Despite the increased incidence of DGF in DCD kidney recipients, long-term graft and patient outcomes were similar between DBD and DCD groups across KDPI categories. This observation is particularly important in the highest KDPI group where there is still higher rates of organ discard. Our findings support more robust utilization of kidneys from DCD donors for transplantation especially from the higher KDPI groups in order to alleviate existing organ shortage.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Chopra B, Sureshkumar KK, Rajasundaram D, Rodrigo EC. Outcomes of Kidney Transplant Recipients (KTRs) Comparing Brain Dead Donors’ vs Donation After Cardiac Death Stratified by KDPI, Focus on Marginal Kidneys: A UNOS Database Analysis [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/outcomes-of-kidney-transplant-recipients-ktrs-comparing-brain-dead-donors-vs-donation-after-cardiac-death-stratified-by-kdpi-focus-on-marginal-kidneys-a-unos-database-analysis/. Accessed May 16, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences